Trial intelligence / Profile preview

IDflu Immunogenicity and Safety in Korean Adults and Elderly

NCT01215669Phase 4Completed

Sponsor
Sanofi
Start
Oct 2010
Primary completion
Feb 2011
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of influenza vaccine in influenza, sponsored by Sanofi. Started Oct 2010; status: completed.

02

Drugs

influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on NCT01215669.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01215669.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call